CoChat

Pimozide suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling pathway

Ren, Yonggang, Tao, Jia, Jiang, Zhen, Guo, Dongmei, Tang, Jiancai · 2018 · Life Sciences
Cited by 45

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Objective: Wnt/&bgr;‐catenin signaling pathway plays important role in colorectal cancer (CRC) and acts as a potential therapeutic target. Pimozide is a FDA‐approved clinical drug used to treat psychotic diseases and it has shown anticancer effect in some tumors partially via inhibition of Wnt/&bgr;‐catenin signaling pathway. This study aimed to investigate whether pimozide exerts anticancer effect on CRC and explore underlying mechanism. Methods and results: Pimozide was administrated to treat HCT116 and SW480 cells. Quantitative real‐time polymerase chain reaction and western blot were used to detect the expression of epithelial‐to‐mesenchymal transition markers and Wnt/&bgr;‐catenin signaling pathway‐related proteins. Cell proliferation and migration were measured by Cell Counting Kit‐8 and Transwell assays respectively. HCT116 and SW480 cells were subcutaneously injected into nude mice and when the volume of tumor grown measureable (approximately 100 mm3) animals were treated with vehicle saline or pimozide at a dose of 25 mg/kg·d by oral gavage and then tumor size was measured at 7, 14, 21 and 28 days post treatment. Pimozide dose‐dependently inhibited cell proliferation and migration in both HCT116 and SW480 cells, increased expression of E‐cadherin and decreased expression of N‐cadherin, vimentin and Snail. In addition, tumor growth was inhibited by pimozide in both HCT116 and SW480 xenografts in vivo. Expression of &bgr;‐catenin and Wnt target genes c‐Myc, cyclin D1, Axin 2 and survivin was reduced by pimozide treatment in both HCT 116 and SW480 cells. Conclusion: Pimozide exerts anticancer effect in CRC via inhibition of wnt/&bgr;‐catenin signaling pathway, suggesting it as a potential therapeutic drug for CRC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.lfs.2018.08.027

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 45

Metadata

Authors
Ren, Y., Tao, J., Jiang, Z., Guo, D., & Tang, J.
Venue
Life Sciences
Publisher
Elsevier BV
Published
2018-09
Volume
209
Pages
267-273
ISSN
0024-3205 (ISSN-L)
OpenAlex
W2887239058
Cited by
45
References
1
FWCI
1.80
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.